Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in COPD-associated pulmonary hypertension
NCT01862536Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2013
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tadalafil in pulmonary hypertension (PH), sponsored by VA Office of Research & Development. Started Oct 2013; status: completed.
02
Drugs
tadalafil
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01862536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01862536.